New Key Statistics Module, Z-Score and F-Score
SHSE:600351 Key Ratios
Market Cap ¥ M | 4,154.40 |
Enterprise Value ¥ M | 3,809.60 |
P/E(ttm) | 20.63 |
PE Ratio without NRI | 20.56 |
Forward PE Ratio | -- |
Price/Book | 1.48 |
Price/Sales | 1.58 |
Price/Free Cash Flow | 8.53 |
Price/Owner Earnings | 32.88 |
Payout Ratio % | 0.52 |
Revenue (TTM) ¥ M | 2,820.00 |
EPS (TTM) ¥ | 0.29 |
Beneish M-Score | -3.04 |
10-y EBITDA Growth Rate % | 0.10 |
5-y EBITDA Growth Rate % | -3.20 |
y-y EBITDA Growth Rate % | 20.70 |
EV-to-EBIT | 15.43 |
EV-to-EBITDA | 15.43 |
PEG | -- |
Shares Outstanding M | 720.00 |
Net Margin (%) | 7.49 |
Operating Margin % | 12.16 |
Pre-tax Margin (%) | 8.52 |
Quick Ratio | 1.64 |
Current Ratio | 2.16 |
ROA % (ttm) | 5.45 |
ROE % (ttm) | 7.12 |
ROIC % (ttm) | 9.78 |
Dividend Yield % | 2.60 |
Altman Z-Score | 4.68 |
SHSE:600351 Number of Guru Trades
SHSE:600351 Volume of Guru Trades
Gurus Latest Trades with SHSE:600351
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600351 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Yabao Pharmaceutical Group Co Ltd Insider Transactions
No Available Data